Abivax Sa ADR (ABVX) Stock Price, Quote & News

Company Profile

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. The company was incorporat...

Industry: Biotechnology

Sector: Healthcare

Phone: 33 1 53 83 09 63

Website: www.abivax.com

Address:

7-11 boulevard Haussmann, Paris, France

67X_ROI_Q1_2026 Mar. 8 at 7:04 PM

$SLS $ABVX - this is why the Share Price has been climbing, and it will continue to Climb until it Absolutely Launches. - The Positive P3 Gps Results open up a $28B Total Addressable Market - worth 40B / $180 Per Share to Big Pharma. - expect the share price the continue climbing until we see the Phase 3 Result and then it will launch ... the entire market will see GPs is getting the FDA Green Light to Generate Tens of billions in real revenue ... not any more complicated than that ...

0 · Reply

dutchiestocks Mar. 8 at 9:50 AM

$ABVX gut feeling

0 · Reply

67X_ROI_Q1_2026 Mar. 8 at 3:26 AM

$SLS $ABVX was a $5 Stock, in the days approaching its P3 Results, it Doubled to $10 on large Vol Increase - like we are seeing here, now. There was a T1 Trading Halt at $10 on the P3 Trial Top Line Result Announcement. Trading Resumed with a GAP UP +600% +600% in an instant to $60 ... and it Continued climbing to a High of $148 - based on P3 Data. - SLS is about to Do Something Similar - and we could see the Top Line Results Any Day Now - this is why the Share Price has been climbing, and it will continue to Climb until it Absolutely Launches. - The Positive P3 Gps Results open up a $28B Total Addressable Market - worth 40B / $180 Per Share to Big Pharma. - expect the share price the continue climbing until we see the Phase 3 Result and then it will launch ... the entire market will see GPs is getting the FDA Green Light to Generate Tens of billions in real revenue ... not any more complicated than that ...

2 · Reply

Hognose Mar. 6 at 4:21 PM

$RYTM buy $SSYS buy $ABVX buy $RAPP buy

0 · Reply

DipinDipout Mar. 6 at 1:50 AM

$ABVX

0 · Reply

Hognose Mar. 5 at 10:56 PM

$DT good range to pick this up. $ABVX

0 · Reply

TheLearningTrader Mar. 5 at 2:34 AM

$ABVX been adding this week below 110 and again today…think maintenance data will take this to new highs Target 150 by end June

0 · Reply

outlawinvestor1 Mar. 4 at 10:58 PM

$ERAS my biggest roi next to $ABVX

1 · Reply

67X_ROI_Q1_2026 Mar. 4 at 9:20 PM

$SLS The Positive Phase 3 Registrational Results will give Gps the Fda Green light to treat 100,000 AML patients currently in remission - CCo estimated $280K on patent, orphan drug rev per patient + 40k to 50K new patients Each Year. - its a $28B TAM - Worth Tens of Billions to Big Pharma. SLS should do a full double up to $10/$12 per share in the Next Days as we Expect the Top Line Results ANY DAY NOW - and then the share price Launches. $ABVX was $5 stock, it doubled to $10 approaching the P3 News - the PR Hit along with a T1 Trading Halt and a +600% Gap UP to $60 to Open - and it KEPT on Climbing to a High of $148 Some thing similar will be happening here. $ABBV Buyout in the triple digits ... MO

0 · Reply

67X_ROI_Q1_2026 Mar. 4 at 5:52 PM

$SLS $ABVX what do you think will happen when Gps P3 Top line Results of 24 Month MOS Gps and BAT at 8 are announced?

0 · Reply

2 Reasons Abivax Stock Could 10X by 2036

2026-02-25T10:30:18.000Z - 11 days ago

BTIG Reiterates Buy Rating for Abivax (ABVX) with $150 Price Target | ABVX Stock News

2026-02-24T12:27:38.000Z - 12 days ago

Wedbush Rates Abivax (ABVX) as Underperform with Cautious Outlook

2026-02-22T19:25:16.000Z - 14 days ago

Abivax (ABVX) Highlights Promising Obefazimod Data at ECCO Congress

Feb 21, 2026, 6:00 AM EST - 15 days ago

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026

ABVX

Feb 17, 2026, 1:25 PM EST - 19 days ago

Alger Mid Cap Growth Fund Q4 2025 Portfolio Update

ABVX ELF NBIS NTRA RBLX

Tue, 10 Feb 2026 20:11:00 -0500 - 26 days ago

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.

Fri, 30 Jan 2026 15:30:00 -0500 - 5 weeks ago

Better Long-Term Buy: This Emerging Player or the Industry Leader?

Jan 29, 2026, 10:30 PM EST - 5 weeks ago

Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance

ABBV ABVX CVLT FIX FTAI GKOS GMAB

Jan 20, 2026, 6:01 AM EST - 6 weeks ago

Abivax CEO dismisses 'noise' around rumored Eli Lilly bid

ABVX LLY

Mon, 19 Jan 2026 15:45:00 -0500 - 6 weeks ago

Prediction: This Healthcare Stock Could Soar by 72% in 2026

Jan 12, 2026, 12:31 PM EST - 7 weeks ago

Abivax: Don't Just Buy The Rumor, Buy The Fundamentals

ABVX

Jan 12, 2026, 9:49 AM EST - 7 weeks ago

France has had no request for investment approval in biotech Abivax - official

ABVX LLY

Jan 12, 2026, 9:32 AM EST - 7 weeks ago

Abivax stock rockets 30% on Eli Lilly takeover speculation

ABVX LLY

Jan 12, 2026, 5:03 AM EST - 7 weeks ago

Abivax Surges on Report Eli Lilly is Preparing $17.5 Billion Bid

ABVX LLY

Jan 12, 2026, 4:38 AM EST - 7 weeks ago

Abivax shares soar 23% as media report reignites M&A chatter

ABVX LLY

Jan 9, 2026, 6:54 AM EST - 2 months ago

A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year

ABVX LLY

Jan 7, 2026, 4:05 PM EST - 2 months ago

Abivax Provides 2026 Corporate Outlook

ABVX

Dec 23, 2025, 6:41 AM EST - 2 months ago

Abivax: Here's Why Eli Lilly Could Want Its Oral Ulcerative Colitis Therapy

ABVX LLY

Mon, 22 Dec 2025 19:09:18 -0500 - 2 months ago

Why Abivax Stock Was on Fire Today

Dec 18, 2025, 4:05 PM EST - 2 months ago

Abivax to be Added to Nasdaq Biotechnology Index

ABVX

Dec 17, 2025, 4:05 PM EST - 2 months ago

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings

ABVX

Dec 11, 2025, 4:11 PM EST - 3 months ago

Abivax: "Strong Buy" On Obefazimod New UC Data And Maintenance Results Coming Q2 2026

ABVX

Dec 10, 2025, 12:42 PM EST - 3 months ago

What's Happening With French Biotech Abivax Stock On Wednesday?

ABVX

Dec 10, 2025, 5:52 AM EST - 3 months ago

French biotech Abivax's shares climb on Eli Lilly bid rumors

ABVX LLY

Tue, 09 Dec 2025 16:45:00 -0500 - 3 months ago

2 Under-the-Radar Stocks That Have Soared This Year

Nov 18, 2025, 12:59 PM EST - 3 months ago

6 Healthcare Stocks With Strong Upward Momentum

ABVX CAH ELAN GH MEDP WGS

Nov 8, 2025, 7:57 AM EST - 4 months ago

Abivax: Phase 3 Data Was A Home Run, Top Target For M&A In 2026

ABVX

Oct 14, 2025, 8:41 AM EDT - 5 months ago

Abivax: Betting Big On The Next Inflammatory Bowel Disease Blockbuster

ABVX

Oct 6, 2025, 12:35 PM EDT - 5 months ago

ABIVAX Société Anonyme (ABVX) Shareholder/Analyst Call Transcript

ABVX

Oct 6, 2025, 11:05 AM EDT - 5 months ago

Why Is Abivax Stock Trading Higher On Monday?

ABVX

Oct 5, 2025, 11:00 AM EDT - 5 months ago

Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data

ABVX

Sep 29, 2025, 4:05 PM EDT - 5 months ago

Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting

ABVX

Sep 23, 2025, 4:05 PM EDT - 5 months ago

Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting

ABVX

Sep 12, 2025, 11:45 AM EDT - 6 months ago

Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review

ABVX

Sep 8, 2025, 4:00 PM EDT - 6 months ago

Abivax Presents First Half 2025 Financial Results

ABVX

Aug 30, 2025, 5:30 AM EDT - 6 months ago

How Hedge Funds Won Big on an Obscure Drugmaker

ABVX

Aug 27, 2025, 12:50 PM EDT - 6 months ago

2 Logical Mid-Cap Biotech Buyout Targets

ABVX MLTX

Thu, 31 Jul 2025 10:00:00 -0400 - 7 months ago

This Stock Is Up by 800% This Year -- but Is It a Buy?

Jul 28, 2025, 4:15 PM EDT - 7 months ago

Abivax Announces Closing of $747.5 Million Public Offering

ABVX

Jul 25, 2025, 2:00 AM EDT - 8 months ago

Abivax Announces Full Exercise of Underwriters' Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)

ABVX

Jul 24, 2025, 4:20 PM EDT - 8 months ago

Abivax: Positive Obefazimod Induction Data Leads To Next 44-Week Maintenance Trial Catalyst

ABVX

Jul 24, 2025, 8:40 AM EDT - 8 months ago

Abivax announces trading resumption of its ordinary shares on Euronext Paris

ABVX

Jul 24, 2025, 8:40 AM EDT - 8 months ago

Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares

ABVX

Jul 24, 2025, 1:30 AM EDT - 8 months ago

Abivax announces temporary trading halt of its ordinary shares on Euronext Paris

ABVX

Jul 23, 2025, 4:15 PM EDT - 8 months ago

Abivax Announces Launch of Public Offering

ABVX

Jul 23, 2025, 3:10 PM EDT - 8 months ago

Abivax: Differentiated Phase 3 Data Ignites A Multi-Billion Dollar Opportunity

ABVX

Jul 19, 2025, 2:23 AM EDT - 8 months ago

Abivax: Good Entry Point Ahead Of The Mega Catalyst - Phase 3 Data Readout

ABVX

Jun 11, 2025, 4:00 PM EDT - 9 months ago

Abivax Announces Results of its June 6, 2025 Annual General Meeting

ABVX

Jun 2, 2025, 4:00 PM EDT - 9 months ago

Abivax Presents First Quarter 2025 Financial Results

ABVX

Jun 2, 2025, 11:00 AM EDT - 9 months ago

Biotech Bull Case, ABVX International Interest, JNJ & LLY Options Trades

JNJ LLY

Apr 29, 2025, 4:05 PM EDT - 11 months ago

Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis

Apr 22, 2025, 4:05 PM EDT - 11 months ago

Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones

Apr 22, 2025, 4:00 PM EDT - 11 months ago

Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors

Mar 26, 2025, 5:05 PM EDT - 1 year ago

Abivax publishes financial reports with the French and U.S. securities regulatory agencies

Mar 24, 2025, 3:30 AM EDT - 1 year ago

Abivax Announces Full Year 2024 Financial Results

Feb 21, 2025, 2:30 AM EST - 1 year ago

Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025

Jan 28, 2025, 2:30 AM EST - 1 year ago

Abivax Publishes 2025 Financial Calendar

Jan 23, 2025, 4:05 PM EST - 1 year ago

Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn's and Colitis Organization 20th Annual Congress

Jan 9, 2025, 11:35 AM EST - 1 year ago

Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment

67X_ROI_Q1_2026 Mar. 8 at 7:04 PM

0 · Reply

dutchiestocks Mar. 8 at 9:50 AM

$ABVX gut feeling

0 · Reply

67X_ROI_Q1_2026 Mar. 8 at 3:26 AM

2 · Reply

Hognose Mar. 6 at 4:21 PM

$RYTM buy $SSYS buy $ABVX buy $RAPP buy

0 · Reply

DipinDipout Mar. 6 at 1:50 AM

$ABVX

0 · Reply

Hognose Mar. 5 at 10:56 PM

$DT good range to pick this up. $ABVX

0 · Reply

TheLearningTrader Mar. 5 at 2:34 AM

$ABVX been adding this week below 110 and again today…think maintenance data will take this to new highs Target 150 by end June

0 · Reply

outlawinvestor1 Mar. 4 at 10:58 PM

$ERAS my biggest roi next to $ABVX

1 · Reply

67X_ROI_Q1_2026 Mar. 4 at 9:20 PM

0 · Reply

67X_ROI_Q1_2026 Mar. 4 at 5:52 PM

$SLS $ABVX what do you think will happen when Gps P3 Top line Results of 24 Month MOS Gps and BAT at 8 are announced?

0 · Reply

BladeKingShadowLordX Mar. 4 at 12:16 AM

$ABVX leadership told me they r commercializing. .. u guys r screwed HA HA HA

2 · Reply

67X_ROI_Q1_2026 Mar. 3 at 8:41 PM

$SLS Guaranteed Money in the Bank for Every SLS Investor - Share Price will Continue to Climb until we See the P3 Results and then it absolutely starts Screaming - and Launches. - $5.52 will Be $52.12 in an instant and Climbing. Just Like $ABVX when it Released its Phase 3 Results. It was a $5 stock - and doubled to $10 in the days approaching its P3 readout. . . It T1 Trading Halted on the News and then GAPPED UP to $60. +600% in an Instant, and it Continued Climbing to a high of $148 ... All Based on P3 data that everyone knew was Due. Just Like SLS Right now. Phase 3 Registrational Results are Coming - Guaranteed, 100% the market will Know GPS is worth $40B+ / $180 per share to Big Pharma, the Instant the P3 Results are announced. - and it won't be long Now. Mark this Post.

1 · Reply

Hognose Mar. 3 at 6:36 PM

$ABVX what did I say

0 · Reply

67X_ROI_Q1_2026 Mar. 3 at 6:17 PM

$SLS Busted the Cervix through the 52 Week High These $5.37 Shares will be $53.37 the Instant the P3 Results are announced - and Climbing. Share Price is Doing Exactly what you would expect - as we are Now in the ANY DAY Now Zone to See FDA Registrational Phase 3 Results, worth $40B / $180 Per Share, the Instant the Market Sees the PR . . . Gps Results are Coming, they are Inevitable. Expect this $5 Stock to be $10 within days and then the Real Launch Begins - following the $ABVX track - from $5 to $10 ahead of its P3 and then a T1 Trading Halt - and Gap UP to, +600% in an Instant, and it Kept Climbing to a High of $148. Something Similar is about to Happen here.

0 · Reply

67X_ROI_Q1_2026 Mar. 3 at 5:06 PM

$SLS $ABVX - does everyone understand this sequence? Enrollment Began Feb 2021/ Ended March/april 2024 52 Individual Patients remaining alive are in trial AT LEAST 24 months - ranging up to 60 months So the 52 Patients are Now IN Trial 24 months, 25 months, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60 months. It is very possible 9 or 10 patients in trial 3 years 4 years 5, are in HOSPICE Currently - and we Could see a Rapid Spate of Events - Institutional Fund Analysts Know this and must reconcile the fact we Could See Top Line Results ANY DAY NOW.

0 · Reply

WhiteFang420 Mar. 3 at 5:06 PM

$ABVX bought here today. GLTA

0 · Reply

Jake_Meehof Mar. 3 at 4:54 PM

$ABVX got more at 107

0 · Reply

Hognose Mar. 3 at 3:58 PM

$ABVX buy here.

0 · Reply

sh3r1ock Mar. 3 at 3:18 PM

$ABVX time to start reloading

0 · Reply

SannieVerraderlijk Mar. 3 at 3:00 PM

$NUVB $CYTK $CRNX Took some starters amidst this carnage, added $ABVX

0 · Reply

67X_ROI_Q1_2026 Mar. 3 at 5:59 AM

$SLS Share Price is Doing Exactly what you would expect - as we are Now in the ANY DAY Now Zone to See FDA Registrational Phase 3 Results, worth $40B / $180 Per Share, the Instant the Market Sees the PR . . . Gps Phase 3 Results are Coming, they are Inevitable. Expect this $5 Stock to be $10 within days and then the Real Launch Begins - following the $ABVX track - from $5 to $10 ahead of its P3 and then a T1 Trading Halt - and Gap UP to, +600% in an Instant, and it Kept Climbing to a High of $148. Something Similar is about to Happen here.

1 · Reply

Hognose Mar. 3 at 1:03 AM

$ABVX Those puts definitely paid from a few days ago, large amount of puts were bought a week ago.

0 · Reply

Market Cap	8.65B
Revenue (ttm)	0.00
Net Income (ttm)	-190.71M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.08

Volume	823,100
Avg Vol	1,255,398
Day's Range	N/A - N/A
Shares Out	79.07M
Stochastic %K	14%
Beta	1.00
Analysts	Strong Sell
Price Target	$149.27